These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2401966)

  • 21. Treatment of an acromegalic cat with the dopamine agonist L-deprenyl.
    Abraham LA; Helmond SE; Mitten RW; Charles JA; Holloway SA
    Aust Vet J; 2002 Aug; 80(8):479-83. PubMed ID: 12224616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pituitary-dependent hyperadrenocorticism in a cat.
    Peterson ME; Steele P
    J Am Vet Med Assoc; 1986 Sep; 189(6):680-3. PubMed ID: 3019973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Octreotide as primary therapy for acromegaly.
    Newman CB; Melmed S; George A; Torigian D; Duhaney M; Snyder P; Young W; Klibanski A; Molitch ME; Gagel R; Sheeler L; Cook D; Malarkey W; Jackson I; Vance ML; Barkan A; Frohman L; Kleinberg DL
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3034-40. PubMed ID: 9745397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SMS 201-995 induces a continuous decline in circulating growth hormone and somatomedin-C levels during therapy of acromegalic patients for over two years.
    Lamberts SW; Uitterlinden P; del Pozo E
    J Clin Endocrinol Metab; 1987 Oct; 65(4):703-10. PubMed ID: 2888785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy.
    Plöckinger U; Reichel M; Fett U; Saeger W; Quabbe HJ
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1416-23. PubMed ID: 7962337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Octreotide in the management of active acromegaly due to inoperable growth hormone-secreting adenoma.
    Candrina R
    Recenti Prog Med; 1994 Jan; 85(1):13-9. PubMed ID: 8184174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis and management of diabetes mellitus in five cats with somatotrophic abnormalities.
    Norman EJ; Mooney CT
    J Feline Med Surg; 2000 Dec; 2(4):183-90. PubMed ID: 11716617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypersomatotropism in 3 Cats without Concurrent Diabetes Mellitus.
    Fletcher JM; Scudder CJ; Kiupel M; Pipe-Martin HN; Kenny PJ; Mantis P; Fenn J; Smith K; Blair RV; Granger LA; Niessen SJ
    J Vet Intern Med; 2016 Jul; 30(4):1216-21. PubMed ID: 27255700
    [No Abstract]   [Full Text] [Related]  

  • 29. Outcomes of pituitary tumor irradiation in cats.
    Mayer MN; Greco DS; LaRue SM
    J Vet Intern Med; 2006; 20(5):1151-4. PubMed ID: 17063708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pasireotide Long-Acting Release Treatment for Diabetic Cats with Underlying Hypersomatotropism.
    Gostelow R; Scudder C; Keyte S; Forcada Y; Fowkes RC; Schmid HA; Church DB; Niessen SJ
    J Vet Intern Med; 2017 Mar; 31(2):355-364. PubMed ID: 28145031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acromegaly.
    Scacchi M; Cavagnini F
    Pituitary; 2006; 9(4):297-303. PubMed ID: 17077948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetic resonance imaging findings in 15 acromegalic cats.
    Posch B; Dobson J; Herrtage M
    Vet Radiol Ultrasound; 2011; 52(4):422-7. PubMed ID: 21447042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional pituitary acidophil adenoma in a cat with diabetes mellitus and acromegalic features.
    Lichtensteiger CA; Wortman JA; Eigenmann JE
    Vet Pathol; 1986 Jul; 23(4):518-21. PubMed ID: 3018986
    [No Abstract]   [Full Text] [Related]  

  • 34. Somatotroph and corticotroph pituitary adenoma (double adenoma) in a cat with diabetes mellitus and hyperadrenocorticism.
    Meij BP; van der Vlugt-Meijer RH; van den Ingh TS; Rijnberk A
    J Comp Pathol; 2004; 130(2-3):209-15. PubMed ID: 15003481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study.
    Plöckinger U; Quabbe HJ
    Acta Neurochir (Wien); 2005 May; 147(5):485-93; discussion 493. PubMed ID: 15806331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feline acromegaly: an essential differential diagnosis for the difficult diabetic.
    Niessen SJ
    J Feline Med Surg; 2010 Jan; 12(1):15-23. PubMed ID: 20123483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transsphenoidal hypophysectomy for the treatment of hypersomatotropism secondary to a pituitary somatotroph adenoma in a dog.
    Steele MME; Lawson JS; Scudder C; Watson AH; Ho NTZ; Yaffy D; Batchelor D; Fenn J
    J Vet Intern Med; 2024; 38(1):351-357. PubMed ID: 37916616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Echocardiographic findings in 11 cats with acromegaly.
    Myers JA; Lunn KF; Bright JM
    J Vet Intern Med; 2014; 28(4):1235-8. PubMed ID: 24962737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complete surgical removal of a very enlarged pituitary corticotroph adenoma in a dog.
    Fracassi F; Mandrioli L; Shehdula D; Diana A; Grinwis GC; Meij BP
    J Am Anim Hosp Assoc; 2014; 50(3):192-7. PubMed ID: 24659728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of a long-acting somatostatin analogue (SMS 201-995) on a growth hormone and thyroid stimulating hormone-producing pituitary tumor.
    Hirasawa R; Hashimoto K; Makino S; Suemaru S; Takao T; Ota Z; Hoshida Y; Yoshino T; Akagi T
    Acta Med Okayama; 1991 Apr; 45(2):107-15. PubMed ID: 1867112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.